JP2021521227A5 - - Google Patents
Info
- Publication number
- JP2021521227A5 JP2021521227A5 JP2020556855A JP2020556855A JP2021521227A5 JP 2021521227 A5 JP2021521227 A5 JP 2021521227A5 JP 2020556855 A JP2020556855 A JP 2020556855A JP 2020556855 A JP2020556855 A JP 2020556855A JP 2021521227 A5 JP2021521227 A5 JP 2021521227A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- composition according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862658347P | 2018-04-16 | 2018-04-16 | |
| US62/658,347 | 2018-04-16 | ||
| PCT/US2019/027158 WO2019204136A1 (en) | 2018-04-16 | 2019-04-12 | Methods of treating neuropathic pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021521227A JP2021521227A (ja) | 2021-08-26 |
| JP2021521227A5 true JP2021521227A5 (enExample) | 2022-04-20 |
Family
ID=68239826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020556855A Withdrawn JP2021521227A (ja) | 2018-04-16 | 2019-04-12 | 神経障害性疼痛を処置する方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210154170A1 (enExample) |
| EP (1) | EP3781157A4 (enExample) |
| JP (1) | JP2021521227A (enExample) |
| KR (1) | KR20210002472A (enExample) |
| CN (1) | CN112367990A (enExample) |
| AU (1) | AU2019255519A1 (enExample) |
| BR (1) | BR112020021101A2 (enExample) |
| CA (1) | CA3093401A1 (enExample) |
| EA (1) | EA202092482A1 (enExample) |
| IL (1) | IL277962A (enExample) |
| MX (1) | MX2020010929A (enExample) |
| SG (1) | SG11202008681PA (enExample) |
| TW (2) | TWI803619B (enExample) |
| WO (1) | WO2019204136A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998007447A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
| TW200730494A (en) * | 2005-10-10 | 2007-08-16 | Glaxo Group Ltd | Novel compounds |
| GB201409851D0 (en) * | 2014-06-03 | 2014-07-16 | Convergence Pharmaceuticals | Diagnostic method |
| GB201417497D0 (en) * | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
| AU2017353841A1 (en) * | 2016-11-02 | 2019-05-30 | Biogen Ma Inc. | Novel dosage regimen |
-
2019
- 2019-04-12 CA CA3093401A patent/CA3093401A1/en not_active Withdrawn
- 2019-04-12 EA EA202092482A patent/EA202092482A1/ru unknown
- 2019-04-12 EP EP19787899.4A patent/EP3781157A4/en not_active Withdrawn
- 2019-04-12 CN CN201980026095.5A patent/CN112367990A/zh not_active Withdrawn
- 2019-04-12 SG SG11202008681PA patent/SG11202008681PA/en unknown
- 2019-04-12 BR BR112020021101-0A patent/BR112020021101A2/pt not_active Application Discontinuation
- 2019-04-12 KR KR1020207028395A patent/KR20210002472A/ko not_active Withdrawn
- 2019-04-12 WO PCT/US2019/027158 patent/WO2019204136A1/en not_active Ceased
- 2019-04-12 MX MX2020010929A patent/MX2020010929A/es unknown
- 2019-04-12 JP JP2020556855A patent/JP2021521227A/ja not_active Withdrawn
- 2019-04-12 US US17/047,570 patent/US20210154170A1/en not_active Abandoned
- 2019-04-12 AU AU2019255519A patent/AU2019255519A1/en not_active Withdrawn
- 2019-04-16 TW TW108113193A patent/TWI803619B/zh not_active IP Right Cessation
- 2019-04-16 TW TW111111744A patent/TW202245750A/zh unknown
-
2020
- 2020-10-12 IL IL277962A patent/IL277962A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (enExample) | ||
| JP2021522247A5 (enExample) | ||
| RU2010140682A (ru) | Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство | |
| JP2014515373A5 (enExample) | ||
| JP2015505564A5 (enExample) | ||
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| JP2015510916A5 (enExample) | ||
| RU2014141893A (ru) | Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких | |
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| EA202190544A1 (ru) | Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний | |
| JP2017514911A5 (enExample) | ||
| AU2018282104A1 (en) | Use of vibegron to treat overactive bladder | |
| JP2008539273A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2019507786A5 (enExample) | ||
| JP2016528171A5 (enExample) | ||
| JP2021521227A5 (enExample) | ||
| RU2012108144A (ru) | Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами | |
| TN2016000179A1 (en) | Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor. | |
| MX2019003720A (es) | Composiciones y metodos para tratar el mal de alzheimer y la enfermedad de parkinson. | |
| JP2022543598A5 (enExample) | ||
| JP2023518430A5 (enExample) | ||
| JP2016521760A5 (enExample) |